ACRS
Price
$3.04
Change
+$0.14 (+4.83%)
Updated
Dec 24 closing price
Capitalization
329.37M
67 days until earnings call
Intraday BUY SELL Signals
NRIX
Price
$19.36
Change
+$0.07 (+0.36%)
Updated
Dec 24 closing price
Capitalization
1.96B
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACRS vs NRIX

Header iconACRS vs NRIX Comparison
Open Charts ACRS vs NRIXBanner chart's image
Aclaris Therapeutics
Price$3.04
Change+$0.14 (+4.83%)
Volume$440.37K
Capitalization329.37M
Nurix Therapeutics
Price$19.36
Change+$0.07 (+0.36%)
Volume$480.46K
Capitalization1.96B
ACRS vs NRIX Comparison Chart in %
ACRS
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACRS vs. NRIX commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRS is a Hold and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (ACRS: $3.04 vs. NRIX: $19.36)
Brand notoriety: ACRS and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRS: 31% vs. NRIX: 24%
Market capitalization -- ACRS: $329.37M vs. NRIX: $1.96B
ACRS [@Biotechnology] is valued at $329.37M. NRIX’s [@Biotechnology] market capitalization is $1.96B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRS’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 0 green FA rating(s).

  • ACRS’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACRS and NRIX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRS’s TA Score shows that 3 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • ACRS’s TA Score: 3 bullish, 5 bearish.
  • NRIX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than ACRS.

Price Growth

ACRS (@Biotechnology) experienced а +0.33% price change this week, while NRIX (@Biotechnology) price change was +6.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

ACRS is expected to report earnings on Mar 03, 2026.

NRIX is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($1.96B) has a higher market cap than ACRS($329M). ACRS YTD gains are higher at: 22.581 vs. NRIX (2.760). ACRS has higher annual earnings (EBITDA): -65.32M vs. NRIX (-248.7M). NRIX has more cash in the bank: 429M vs. ACRS (95.9M). NRIX has higher revenues than ACRS: NRIX (83.7M) vs ACRS (15.7M).
ACRSNRIXACRS / NRIX
Capitalization329M1.96B17%
EBITDA-65.32M-248.7M26%
Gain YTD22.5812.760818%
P/E RatioN/AN/A-
Revenue15.7M83.7M19%
Total Cash95.9M429M22%
Total DebtN/A56.5M-
FUNDAMENTALS RATINGS
ACRS: Fundamental Ratings
ACRS
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACRSNRIX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ACRS
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VBAMF0.190.02
+10.76%
AVENTIS ENERGY INC.
ZFSVF789.5127.17
+3.56%
Zurich Insurance Group Ltd
KIKOY17.92N/A
N/A
Kikkoman Corp.
NXCLF1.25N/A
N/A
Lifull Co Ltd
TOPCF21.22N/A
N/A
Topcon Corp.

ACRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRS has been loosely correlated with STRRP. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRS jumps, then STRRP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRS
1D Price
Change %
ACRS100%
+4.83%
STRRP - ACRS
52%
Loosely correlated
-0.11%
MYNZ - ACRS
40%
Loosely correlated
+1.74%
ARWR - ACRS
40%
Loosely correlated
+0.40%
UFPT - ACRS
39%
Loosely correlated
+1.23%
NRIX - ACRS
38%
Loosely correlated
+0.36%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+0.36%
KYMR - NRIX
65%
Loosely correlated
-0.48%
KURA - NRIX
56%
Loosely correlated
+2.50%
XNCR - NRIX
55%
Loosely correlated
-0.13%
SYRE - NRIX
54%
Loosely correlated
-0.54%
OCUL - NRIX
53%
Loosely correlated
-0.24%
More